You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Aranesp®

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Kidney Disease Trial in Ho Chi Minh City (Stimus)

Active, not recruiting
  • Chronic Kidney Disease
  • Stimus
  • Ho Chi Minh City, Vietnam
    NANOGEN Pharmaceutical Biotechnology JSC
Nov 23, 2022

Anemia, Chronic Kidney Disease Requiring Chronic Dialysis Trial in Ho Chi Minh City (Stimus (NNG-DEPO))

Active, not recruiting
  • Anemia
  • Chronic Kidney Disease Requiring Chronic Dialysis
  • Stimus (NNG-DEPO)
  • Ho Chi Minh City, Vietnam
    NANOGEN Pharmaceutical Biotechnology JSC
Jan 4, 2023

Erythropoietin Adverse Reaction Trial in Roskilde (Acetylsalicylic acid)

Recruiting
  • Erythropoietin Adverse Reaction
  • Acetylsalicylic acid
  • Roskilde, Denmark
    Medicinsk afdeling, SUH Roskilde
Aug 15, 2022

Anemia, Cancer Trial in Lebanon (darbepoetin alfa)

Completed
  • Anemia
  • Cancer
  • darbepoetin alfa
  • Lebanon, New Hampshire
    Norris Cotton Cancer Center
Sep 17, 2021

Diabetes Complications, Diabetes; Nephropathy (Manifestation) Trial in Stockholm (Roxadustat, Darbepoietin Alfa)

Not yet recruiting
  • Diabetes Complications
  • Diabetes; Nephropathy (Manifestation)
  • Stockholm, Sweden
    Centre for diabetes
Apr 11, 2023

Dialysis Trial in Murray (Algorithm model-based Aranesp doses, Standard of care)

Not yet recruiting
  • Dialysis
  • Algorithm model-based Aranesp doses
  • Standard of care
  • Murray, Utah
  • +1 more
Jun 27, 2023

MDS Trial in Tampa (Canakinumab Injection, Darbepoetin Alfa)

Recruiting
  • Myelodysplastic Syndromes
  • Canakinumab Injection
  • Darbepoetin Alfa
  • Tampa, Florida
    Moffitt Cancer Center
Nov 21, 2022

Symptomatic Anemia Trial in Zuidlaren (DA3880, Aranesp)

Completed
  • Symptomatic Anemia
  • Zuidlaren, Netherlands
    PRA
Jun 13, 2021

Prematurity, Iron-deficiency, Iron Deficiency Anemia Trial in Seattle (Darbepoetin Alfa, Low Molecular Weight Iron Dextran,

Recruiting
  • Prematurity
  • +3 more
  • Darbepoetin Alfa
  • +3 more
  • Seattle, Washington
    University of Washington
Dec 13, 2022

PAIS, Neonatal Stroke, Perinatal Stroke Trial in Utrecht (Darbepoetin Alfa, Saline)

Recruiting
  • PAIS
  • +2 more
  • Utrecht, Netherlands
    Wilhelmina Childrens Hostpital/University Medical Center Utrecht
Oct 6, 2021

Healthy Trial in Saint Petersburg (BCD-066, Aranesp)

Completed
Has Results
  • Healthy
  • BCD-066
  • Aranesp
  • Saint Petersburg, Strelna, Russian Federation
    BIOCAD
Apr 8, 2020

Myocardial Glucose Uptake (MGU) in Chronic Kidney Disease

Completed
Has Results
  • Cardiomyopathy
  • +2 more
  • Darbepoetin alfa
  • Baltimore, Maryland
    Baltimore VA Medical Center
May 11, 2020

Erythropoiesis Stimulating Agents for Anemia Management in

Completed
  • Anemia of Chronic Kidney Disease
  • +2 more
    • Giza, Egypt
      the Memorial Souad Kafafi University Hospital
    Jan 24, 2023

    Chronic Kidney Disease, End Stage Renal Failure on Dialysis, Anemia Trial in Russian Federation (Darbepoetin alfa)

    Completed
    Has Results
    • Chronic Kidney Disease
    • +2 more
    • Darbepoetin alfa
    • Belgorod, Russian Federation
    • +29 more
    Apr 21, 2020

    Reticulocyte Count Trial (BCD-131, Mircera®, Aranesp®)

    Completed
    Has Results
    • Reticulocyte Count
    • BCD-131
    • +2 more
    • (no location specified)
    Apr 8, 2019

    Anemia, Chronic Kidney Disease Trial (Epoetin Alfa, Darbepoetin alfa)

    Completed
    Has Results
    • Anemia
    • Chronic Kidney Disease
    • Epoetin Alfa
    • Darbepoetin alfa
    • (no location specified)
    Aug 16, 2019

    Erythroblastosis, Fetal, Erythroblastosis Fetalis, Rh Disease, Erythroblastosis Fetalis Due to RH Antibodies Trial in Leiden

    Unknown status
    • Erythroblastosis, Fetal
    • +3 more
    • Darbepoetin Alfa
    • Leiden, Netherlands
      Leiden University Medical Center
    Sep 30, 2019

    Sarcoma Trial in Houston (Aranesp (darbepoetin alfa), Neulasta (pegfilgrastim), Adriamycin)

    Completed
    • Sarcoma
    • Aranesp (darbepoetin alfa)
    • +3 more
    • Houston, Texas
      UT MDAnderson Cancer Center
    Nov 5, 2018

    Kidney Disease, Diabetes, Anemia Trial (Placebo, darbepoetin alfa)

    Completed
    Has Results
    • Kidney Disease
    • +2 more
    • Placebo
    • darbepoetin alfa
    • (no location specified)
    Sep 20, 2018

    Anemia in Chronic Kidney Disease in Non-dialysis Patients Trial in Worldwide (Roxadustat, Darbepoetin alfa)

    Completed
    Has Results
    • Anemia in Chronic Kidney Disease in Non-dialysis Patients
    • Vienna, Austria
    • +124 more
    Apr 19, 2021

    Anemia Trial (Darbepoetin alfa, Placebo)

    Completed
    • Anemia
    • Darbepoetin alfa
    • Placebo
    • (no location specified)
    Dec 18, 2018

    Atrial Fibrillation Trial in Genk (Heart rhythm measurements with Preventicus®, Heart rhythm measurements with FibriCheck®,

    Recruiting
    • Atrial Fibrillation
    • Heart rhythm measurements with Preventicus®
    • +3 more
    • Genk, Limburg, Belgium
      Ziekenhuis Oost-Limburg
    Aug 28, 2023

    ECMO Braile Biomédica® in COVID-19 Patients

    Recruiting
    • COVID-19
    • Patients underwent cardiorespiratory support
    • Lago Sul, Brasília - DF, Brazil
      Hospital Brasília
    Oct 13, 2023

    Myelodysplastic Syndrome (MDS) Trial in Belgium (Darbepoetin Alfa)

    Completed
    Has Results
    • Myelodysplastic Syndrome (MDS)
    • Darbepoetin Alfa
    • Charleroi, Belgium
    • +3 more
    Oct 15, 2018

    Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,

    Not yet recruiting
    • Metastatic Gastric Adenocarcinoma
    • +2 more
    • nal-IRI /Experimental
    • +2 more
    • (no location specified)
    Jun 25, 2023